220 related articles for article (PubMed ID: 26270237)
1. Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against Trypanosoma brucei.
Schulze CJ; Donia MS; Siqueira-Neto JL; Ray D; Raskatov JA; Green RE; McKerrow JH; Fischbach MA; Linington RG
ACS Chem Biol; 2015 Oct; 10(10):2373-81. PubMed ID: 26270237
[TBL] [Abstract][Full Text] [Related]
2. Anti-trypanosomal compound, sagamilactam, a new polyene macrocyclic lactam from Actinomadura sp. K13-0306.
Kimura T; Iwatsuki M; Asami Y; Ishiyama A; Hokari R; Otoguro K; Matsumoto A; Sato N; Shiomi K; Takahashi Y; Ōmura S; Nakashima T
J Antibiot (Tokyo); 2016 Nov; 69(11):818-824. PubMed ID: 27025350
[TBL] [Abstract][Full Text] [Related]
3. Genome-Guided Discovery of Pretilactam from
Wang J; Hu X; Sun G; Li L; Jiang B; Li S; Bai L; Liu H; Yu L; Wu L
Molecules; 2019 Jun; 24(12):. PubMed ID: 31248172
[No Abstract] [Full Text] [Related]
4. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery.
Boniface PK; Elizabeth FI
Curr Drug Targets; 2019; 20(12):1295-1314. PubMed ID: 31215385
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.
Pizarro JC; Hills T; Senisterra G; Wernimont AK; Mackenzie C; Norcross NR; Ferguson MA; Wyatt PG; Gilbert IH; Hui R
PLoS Negl Trop Dis; 2013; 7(10):e2492. PubMed ID: 24147171
[TBL] [Abstract][Full Text] [Related]
6. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads.
Jain S; Jacob M; Walker L; Tekwani B
BMC Complement Altern Med; 2016 May; 16():131. PubMed ID: 27193901
[TBL] [Abstract][Full Text] [Related]
7. Iheyamides A-C, Antitrypanosomal Linear Peptides Isolated from a Marine
Kurisawa N; Iwasaki A; Jeelani G; Nozaki T; Suenaga K
J Nat Prod; 2020 May; 83(5):1684-1690. PubMed ID: 32352773
[TBL] [Abstract][Full Text] [Related]
8. Novel triazine dimers with potent antitrypanosomal activity.
Venkatraj M; Salado IG; Heeres J; Joossens J; Lewi PJ; Caljon G; Maes L; Van der Veken P; Augustyns K
Eur J Med Chem; 2018 Jan; 143():306-319. PubMed ID: 29197735
[TBL] [Abstract][Full Text] [Related]
9. QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors.
Masand VH; El-Sayed NN; Mahajan DT; Rastija V
SAR QSAR Environ Res; 2017 Feb; 28(2):165-177. PubMed ID: 28235390
[TBL] [Abstract][Full Text] [Related]
10. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
11. Kenalactams A-E, Polyene Macrolactams Isolated from Nocardiopsis CG3.
Messaoudi O; Sudarman E; Bendahou M; Jansen R; Stadler M; Wink J
J Nat Prod; 2019 May; 82(5):1081-1088. PubMed ID: 31021629
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
[TBL] [Abstract][Full Text] [Related]
13. Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis.
Zhao Y; Wang Q; Meng Q; Ding D; Yang H; Gao G; Li D; Zhu W; Zhou H
Bioorg Med Chem; 2012 Feb; 20(3):1240-50. PubMed ID: 22249121
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.
Lavrado J; Mackey Z; Hansell E; McKerrow JH; Paulo A; Moreira R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6256-60. PubMed ID: 22926067
[TBL] [Abstract][Full Text] [Related]
16. Antiprotozoal activities of new bis-chlorophenyl derivatives of bicyclic octanes and aza-nonanes.
Berger H; Seebacher W; Saf R; Kaiser M; Brun R; Weis R
Bioorg Med Chem Lett; 2006 Oct; 16(20):5457-61. PubMed ID: 16889962
[TBL] [Abstract][Full Text] [Related]
17. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
Don R; Ioset JR
Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
[TBL] [Abstract][Full Text] [Related]
18. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.
Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH
Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842
[TBL] [Abstract][Full Text] [Related]
19. New antiprotozoal agents: their synthesis and biological evaluations.
Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
